Skip to main content
SpringerLink
Log in
Book cover

Verhandlungen der Schweizerischen Gesellschaft für Gynäkologie und Geburtshilfe pp 92–97Cite as

Perspectives et alternatives

  • Chapter

  • 11 Accesses

Part of the book series: Archives of Gynecology and Obstetrics ((AGYO))

Résumé

Dans le traitement des effets de la ménopause, les oestrogènes ont fait leur preuve en palliant à toutes les manifestations cliniques apparentes et inapparentes de l’extinction de la fonction ovarienne [2]. Toutefois, même en association avec un progestatif, et dans une certaine mesure à cause de cette association avec un progestatif [7], les traitements substitutifs à base d’oestrogènes donnent lieu à des effets secondaires qui rendent souhaitable de disposer de solutions alternatives et incitent à développer de nouvelles formes de traitement, par exemple par le choix d’autres formes galéniques ou la mise au point de nouvelles molécules. Quelles sont donc les perspectives dans ce domaine?

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliographie

  1. Birkhäuser MH (1988) Central and peripheral effects of vaginal estrogen therapy. In: Genazzani AR, Montemagno V, Nappi C, Petraglia F (eds) The brain and female reproduction function. Parthenon, Casterton Hall, pp 601–608

    Google Scholar 

  2. Christiansen C (1988) Estrogentherapy of osteoporosis. Dans: The Proceedings of a Special Symposium held at the First Congress of the International Society of Gynecological Endocrinology. In: Christiansen C (ed) New horizons in osteoporosis. Parthenon, Casterton Hall, pp 13–19

    Google Scholar 

  3. Clayden JR, Bell JW, Pollard P (1974) Menopausal flushing: double-blind trial of a non-hormonal medication. Br Med J 1: 409–412

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. David A, Don R, Tajchner G, Weissglas L (1988) Vaeralipride: alternative antidopaminergic treatment for menopausal symptoms. Am J Obstet Gynecol 158: 1107–1115

    Article  CAS  PubMed  Google Scholar 

  5. De Aloysio D, Fabiani AG, Maufoni M, Bottiglioni F (1987) Use of Org OD 14 for the treatment of climateric complaints. Maturitas [Suppl] 1: 49–65

    Article  Google Scholar 

  6. Delanian L (1980) Etude clinique de l’activité d’une nouvelle molécule de veralipride sur les troubles psychoneuro-végétatifs de la ménopause. Sem Hop Paris 56: 1468–1470

    CAS  PubMed  Google Scholar 

  7. Don Gambrell R jr (1987) Estrogen replacement therapy — guidelines for safe use. Drug Therapy 68: 80

    Google Scholar 

  8. Edington RF, Chagman JP, Steinberg WM (1980) Clonidine (Dixarit) for menopausal flushing. Can Med Assoc J 123: 23–26

    CAS  PubMed Central  PubMed  Google Scholar 

  9. Ginsburg J, Reilly O, Swinhoe J (1985) Effect of oral Clonidine on human cardiovascular responsiveness: a possible explanation of the therapeutic action of the drug in menopausal flushing and migraine. Br J Obstet Gynaecol 92: 1169–1175

    Article  CAS  PubMed  Google Scholar 

  10. Holmgren PA, Lindskog M, von Schoultz B (1989) Vaginal rings for continuous lowdose release of oestradiol in the treatment of urogenital atrophy. Maturitas 11: 55–63

    Article  CAS  PubMed  Google Scholar 

  11. Keller PJ (1988) Transdermal systems for estrogentherapy in menopause. In: Genazzani AR, Montemagno V, Nappi C, Petraglia F (eds) The brain and female reproduction. Parthenon, Casterton Hall, pp 601–609

    Google Scholar 

  12. Keller PJ (1988) Combined transdermal hormone therapy. In: Genazzani AR, Petraglia F, Volpe A, Facchinetti F (eds) Advances in gynaecological andocrinology. Parthenon, Carnforth, pp 651–657

    Google Scholar 

  13. Kicovic PM, Cortes-Prieto J, Luisi M, Milojevic S, Franchi F (1982) Placebo-controlled crossover study of effects of Org OD 14 in menopausal women. Reproduction 6: 81–91

    CAS  Google Scholar 

  14. Kicovic PM (1988) New steroid for the climateric syndrome. In: Gemazzani AR, Montemagno V, Nappi C, Petraglia F (eds) The brain and female reproductive function. Parthenon, Casterton Hall, pp 610–616

    Google Scholar 

  15. Laufer LR (1982) Effect of Clonidine on hot flashes in postmenopausal women. Obstet Gynecol 60: 583–586

    CAS  PubMed  Google Scholar 

  16. Linquette M, Riviere J, Vague J (1980) Traitement non hormonal des troubles de la ménopause — étude multicentrique en double insu. Sem Hop Paris 56: 1445–1448

    CAS  PubMed  Google Scholar 

  17. Lufkin EG, Carpenter PC, Ory SJ, Malkesian GD, Edmonson J-H (1988) Estrogen replacement therapy: current recommendations. Mayo Clin Proc 63: 453–460

    Article  CAS  PubMed  Google Scholar 

  18. Metzger DA, Hammond CB (1988) Are estrogens indicated for the treatment of postmenopausal women. Drug Intell Clin Pharm 22: 493–496

    CAS  PubMed  Google Scholar 

  19. Mishell DR, Moore DE, Roy S, Brenner PF, Page MA (1978) Clinical performance and endocrine profile with contraceptive vaginal ring containing a combination of estradiol and d-norgestrel. Am J Obstet Gynecol 130: 55–62

    CAS  PubMed  Google Scholar 

  20. Nagomani M, Kelver ME, Smith ER (1987) Treatment of menopausal hot flashes with transdermal administration of Clonidine. Am J Obstet Gynecol 156: 561–565

    Article  Google Scholar 

  21. Reginster JY, Denis D, Albert A, Deroisy R, Leeart MP, Fontaine MA, Franchimont P (1988) Intranasal calcitonin: a new horizon in prevention of early postmenopausal boneloss. In: Christiansen C (ed) New horizons in osteoporosis. Parthenon, Carnforth, pp 27–35

    Google Scholar 

  22. Riis BJ, Christiansen C, Overgaard K (1988) The effect of nasal calcitonine on postmenopausal oestoporosis. In: Christiansen C (ed) New horizons in osteoporosis. Parthenon, Carnforth, pp 37–41

    Google Scholar 

  23. Sandrin R, Evrard G, Adnet JJ, Wahl P, Quereux C (1980) Etude cytologique hormonale des frottis vaginaux avant et après traitement par veralipride. Sem Hop Paris 56: 1460–1464

    Google Scholar 

  24. Salmi T, Punnonen R (1979) Clonidine in the treatment of menopausal symptoms. Int J Gynaecol Obstet 16: 422–426

    CAS  PubMed  Google Scholar 

  25. Sitruk-Ware R (1988) Editorial. Maturitas 10: 79–81

    Article  CAS  PubMed  Google Scholar 

  26. Stevenson JC, Cush MP, Ganger KF (1988) Calcitonin and estrogen in the management of osteoporosis. In: Christiansen C (ed) New horizons in oestoporosis. Parthenon, Carnforth, pp 21–26

    Google Scholar 

  27. Tax L, Goorissen EM, Kicovic PM (1987) Clinical profile of Org OD 14. Maturitas [Suppl] 1: 3–13

    Article  Google Scholar 

  28. Treroux R, Dieulangard P, Blum A (1983) Efficacy and safety of Org OD 14 in the treatment of climateric complaints. Maturitas 5: 89–96

    Article  Google Scholar 

  29. Tulandi T, Lal S, Kinch RA (1983) Effect of intravenous Clonidine on menopausal flushing and luteinizing hormone secretion. Br J Obstet Gynaecol 90: 854–857

    Article  CAS  PubMed  Google Scholar 

  30. Verbeke K, Dhout M, van de Kerckhove D (1988) Clinical and hormonal effects of long-term veralipride treatment in post-menopausal women. Maturitas 10: 225–230

    Article  CAS  PubMed  Google Scholar 

  31. Wesel S, Bosuma WB (1983) L’alternative au traitement hormonal des bouffées vasomotrices de la ménopause: le veralipride. Sem Hop Paris 59: 596–599

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Département de Gynécologie-Obstétrique, CHUV, CH-1011, Lausanne, Swiss

    H. J. Welti

Authors
  1. H. J. Welti
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Welti, H.J. (1989). Perspectives et alternatives. In: Verhandlungen der Schweizerischen Gesellschaft für Gynäkologie und Geburtshilfe. Archives of Gynecology and Obstetrics. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-37810-6_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-37810-6_14

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-37102-2

  • Online ISBN: 978-3-662-37810-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation